Topics

IL-6 Inhibitor Cuts NMO Relapse Rates

13:30 EDT 11 Sep 2019 | MedPageToday

(MedPage Today) -- Satralizumab reduces attacks in neuromyelitis optica spectrum disorder

Original Article: IL-6 Inhibitor Cuts NMO Relapse Rates

NEXT ARTICLE

More From BioPortfolio on "IL-6 Inhibitor Cuts NMO Relapse Rates"

Quick Search